Julia Praena

1.1k total citations
8 papers, 115 citations indexed

About

Julia Praena is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Julia Praena has authored 8 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Applied Microbiology and Biotechnology, 3 papers in Clinical Biochemistry and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Julia Praena's work include Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Innovations in Medical Education (3 papers). Julia Praena is often cited by papers focused on Antibiotic Use and Resistance (5 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Innovations in Medical Education (3 papers). Julia Praena collaborates with scholars based in Spain, Sweden and France. Julia Praena's co-authors include Jesús Rodríguez‐Baño, José Molina, José Miguel Cisneros, Germán Peñalva, Jerónimo Pachón, Sonsoles Salto‐Alejandre, Guillermo Martín-Gutiérrez, Juan Colmenero, José Antonio Lepe and Francisco López‐Medrano and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and Antibiotics.

In The Last Decade

Julia Praena

8 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Praena Spain 7 76 45 26 24 17 8 115
Evelyn Wesangula Kenya 5 95 1.3× 46 1.0× 9 0.3× 18 0.8× 21 1.2× 15 148
J-F. Timsit France 5 60 0.8× 36 0.8× 16 0.6× 36 1.5× 14 0.8× 20 126
Rodolfo Quirós Argentina 9 70 0.9× 24 0.5× 19 0.7× 39 1.6× 35 2.1× 26 181
Dana Bakdach Qatar 5 37 0.5× 26 0.6× 30 1.2× 28 1.2× 20 1.2× 9 127
Ana Vega United States 6 55 0.7× 60 1.3× 33 1.3× 62 2.6× 53 3.1× 19 163
Sally Wellsteed United Kingdom 4 91 1.2× 22 0.5× 18 0.7× 25 1.0× 13 0.8× 4 117
Marisa Lanzman United Kingdom 3 78 1.0× 13 0.3× 28 1.1× 34 1.4× 32 1.9× 3 117
Adrien M. Hodonou Benin 4 58 0.8× 32 0.7× 7 0.3× 17 0.7× 15 0.9× 9 109
Ines Pauwels Belgium 7 93 1.2× 23 0.5× 12 0.5× 20 0.8× 8 0.5× 19 106
Loice Achieng Ombajo Kenya 6 83 1.1× 23 0.5× 10 0.4× 50 2.1× 39 2.3× 17 152

Countries citing papers authored by Julia Praena

Since Specialization
Citations

This map shows the geographic impact of Julia Praena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Praena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Praena more than expected).

Fields of papers citing papers by Julia Praena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Praena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Praena. The network helps show where Julia Praena may publish in the future.

Co-authorship network of co-authors of Julia Praena

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Praena. A scholar is included among the top collaborators of Julia Praena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Praena. Julia Praena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Guisado-Gil, Ana Belén, Germán Peñalva, Manuela Aguilar‐Guisado, et al.. (2024). Antimicrobial Stewardship in the Emergency Department Observation Unit: Definition of a New Indicator and Evaluation of Antimicrobial Use and Clinical Outcomes. Antibiotics. 13(4). 356–356. 2 indexed citations
2.
Guisado-Gil, Ana Belén, Carmen Infante-Domínguez, Germán Peñalva, et al.. (2020). Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections. Antibiotics. 9(11). 816–816. 40 indexed citations
3.
4.
Dyar, Oliver J., José Luís del Pozo, Juan Colmenero, et al.. (2018). La formación de grado en enfermedades infecciosas, resistencia y uso de antibióticos desde la perspectiva de los estudiantes de Medicina. Enfermedades Infecciosas y Microbiología Clínica. 37(1). 25–30. 9 indexed citations
5.
Dyar, Oliver J., José Luís del Pozo, Juan Colmenero, et al.. (2018). Perspective of Spanish medical students regarding undergraduate education in infectious diseases, bacterial resistance and antibiotic use. Enfermedades infecciosas y microbiologia clinica (English ed ). 37(1). 25–30. 16 indexed citations
6.
Pérez-Moreno, María Antonia, Germán Peñalva, Julia Praena, et al.. (2018). Evaluation of the impact of a nationwide massive online open course on the appropriate use of antimicrobials. Journal of Antimicrobial Chemotherapy. 73(8). 2231–2235. 8 indexed citations
7.
Morales, Isabel, Lorena López‐Cerero, José Molina, et al.. (2017). Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes. International Journal of Antimicrobial Agents. 49(4). 498–502. 14 indexed citations
8.
Delgado-Valverde, Mercedes, Benito Almirante, Sílvia Gómez-Zorrilla, et al.. (2015). Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project. Journal of Antimicrobial Chemotherapy. 71(2). 521–530. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026